Addiction Consultation Valuable for Liver Transplant Patients

Share this content:
Addiction Consultation Valuable for Liver Transplant Patients
Addiction Consultation Valuable for Liver Transplant Patients

WEDNESDAY, Dec. 14, 2016 (HealthDay News) -- Liver transplantation (LT) patients should undergo addiction consultation to accurately detect alcohol consumption, according to a study published online Dec. 9 in Alcoholism: Clinical & Experimental Research.

Hélène Donnadieu-Rigole, M.D., from Saint-Eloi Hospital in Montpellier, France, and colleagues compared the evaluation of alcohol consumption after LT performed routinely during the transplant consultation or from an addiction consultant in a prospective monocentric study. The alcohol status of 141 patients was assessed using three different scores as patients were seen by a hepatologist, an addiction specialist, and completed the Alcohol Use Disorders Identification Test (AUDIT).

The researchers found that the prevalence of alcohol consumption varied according to the source and was identified in 21.9 percent of patients by the hepatologist, 36.8 percent using the AUDIT questionnaire, and 41.1 percent by the addiction specialist. The patients identified by the hepatologist reported an average of 6.5-alcohol units/week to the transplant specialist; when they were interviewed by the addiction specialist this number increased significantly to 8.6-units/week (P = 0.001).

"This study highlights the interest of a systematic addiction consultation among liver transplant patients, whatever the cause of transplantation," the authors write.

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Vit D Independently, Inversely Tied to Cholesterol in Children

Vit D Independently, Inversely Tied to Cholesterol in ...

Gene variants do not modify the associations of 25(OH)D with lipids

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Ibalizumab Active in Multidrug Resistant HIV-1 Infection

Lower degree of susceptibility to ibalizumab for nine of 10 patients with virology failure, rebound

Weight Gain After Quitting Smoking May Up T2DM Risk

Weight Gain After Quitting Smoking May Up T2DM ...

But temporary increase in type 2 diabetes risk does not attenuate benefits on total, CVD mortality

is free, fast, and customized just for you!




Already a member?

Sign In Now »